Literature DB >> 2121112

Human immunodeficiency virus infection among homeless men in a New York City shelter. Association with Mycobacterium tuberculosis infection.

R A Torres1, S Mani, J Altholz, P W Brickner.   

Abstract

The human immunodeficiency virus (HIV) seroprevalence among a selected sample of 169 high-risk homeless men residing in a congregate shelter in New York City, NY, was 62%. Seropositivity for HIV correlated significantly with intravenous drug use (odds ratio, 3.3; 95% confidence interval, 1.4 to 4.4) and active tuberculosis (odds ratio, 7.0; 95% confidence interval, 3.4 to 13.5). Most cases of active tuberculosis were among homeless men with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex; and significant CD4 lymphocyte depletion was associated with active tuberculosis. Total time homeless correlated positively with active and latent tuberculosis infection. Compliance rates with return for HIV antibody test results, medications, and follow-up visits were 70%, suggesting a significant degree of knowledge, awareness, and personal concern regarding HIV infection among homeless men; yet 28% of homeless intravenous drug users continue active drug injection, despite HIV infection. Cohabitation in overcrowded congregate dormitories creates a risk of airborne transmission of tuberculosis, which is a common reactivation infection in HIV-seropositive homeless men. Medically appropriate housing should be provided to such homeless persons, and expanded HIV antibody testing, counseling, and medical services on site should be offered to residents of shelters.

Entities:  

Mesh:

Year:  1990        PMID: 2121112

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  34 in total

Review 1.  Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration.

Authors:  Sandro Galea; David Vlahov
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

2.  Homelessness and clinical ethics.

Authors:  John Song
Journal:  HEC Forum       Date:  2002-09

3.  HIV seroprevalence among homeless and marginally housed adults in San Francisco.

Authors:  Marjorie J Robertson; Richard A Clark; Edwin D Charlebois; Jacqueline Tulsky; Heather L Long; David R Bangsberg; Andrew R Moss
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

4.  Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting.

Authors:  M-J Milloy; Thomas Kerr; David R Bangsberg; Jane Buxton; Surita Parashar; Silvia Guillemi; Julio Montaner; Evan Wood
Journal:  AIDS Patient Care STDS       Date:  2011-11-22       Impact factor: 5.078

5.  Screening and treatment of immigrants and refugees to Canada for tuberculosis: Implications of the experience of Canada and other industrialized countries.

Authors:  R E Thomas; B Gushulak
Journal:  Can J Infect Dis       Date:  1995-09

6.  Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS.

Authors:  Daniel P Kidder; Richard J Wolitski; Michael L Campsmith; Glenn V Nakamura
Journal:  Am J Public Health       Date:  2007-10-30       Impact factor: 9.308

7.  Health care for the homeless: what we have learned in the past 30 years and what's next.

Authors:  Cheryl Zlotnick; Suzanne Zerger; Phyllis B Wolfe
Journal:  Am J Public Health       Date:  2013-10-22       Impact factor: 9.308

8.  The dual epidemics of tuberculosis and AIDS: ethical and policy issues in screening and treatment.

Authors:  R Bayer; N N Dubler; S Landesman
Journal:  Am J Public Health       Date:  1993-05       Impact factor: 9.308

9.  Commentary: tuberculosis in New York City--the consequences and lessons of failure.

Authors:  S H Landesman
Journal:  Am J Public Health       Date:  1993-05       Impact factor: 9.308

10.  Impact of housing on the survival of persons with AIDS.

Authors:  Sandra K Schwarcz; Ling C Hsu; Eric Vittinghoff; Annie Vu; Joshua D Bamberger; Mitchell H Katz
Journal:  BMC Public Health       Date:  2009-07-07       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.